Analysts: Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

6.65USD
2 Mar 2015
Change (% chg)

-- (--)
Prev Close
$6.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
247,497
52-wk High
$7.83
52-wk Low
$3.15

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 3 Mar 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 2 3.60 3.70 3.50 --
Quarter Ending Jun-15 2 3.65 4.40 2.90 --
Year Ending Dec-15 4 35.70 64.88 23.10 24.78
Earnings (per share)
Quarter Ending Mar-15 2 -0.14 -0.13 -0.14 --
Quarter Ending Jun-15 2 -0.14 -0.13 -0.16 --
Year Ending Dec-15 4 -0.24 0.33 -0.48 -0.64

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 2.53 41.66 39.12 1,543.56
Quarter Ending Jun-14 2.82 1.48 1.35 47.71
Quarter Ending Mar-14 2.88 1.82 1.06 36.96
Quarter Ending Dec-13 1.48 2.97 1.49 101.08
Quarter Ending Sep-13 2.00 0.87 1.14 56.72
Earnings (per share)
Quarter Ending Sep-14 -0.16 0.52 0.68 -435.48
Quarter Ending Jun-14 -0.14 -0.17 0.03 -24.36
Quarter Ending Mar-14 -0.15 -0.15 0.00 -0.00
Quarter Ending Dec-13 -0.19 -0.14 0.05 -25.01
Quarter Ending Sep-13 -0.22 -0.17 0.05 -20.93

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 3.60 3.60 3.60 3.60 --
Quarter Ending Jun-15 3.65 3.66 3.66 3.66 --
Year Ending Dec-15 35.70 35.71 35.71 35.71 24.78
Earnings (per share)
Quarter Ending Mar-15 -0.14 -0.14 -0.14 -0.14 --
Quarter Ending Jun-15 -0.14 -0.14 -0.14 -0.14 --
Year Ending Dec-15 -0.24 -0.24 -0.24 -0.24 -0.64

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 1 0 1
Year Ending Dec-15 0 1 0 1
Earnings
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks